INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Maltzman Julia D. reported ACET

Chief Medical Officer · Adicet Bio, Inc. · Adicet Bio, Inc. — Stock Option (Right to Buy)

Side
A
Value
—
Shares
72.6K
Price
—
Executed
Mar 25, 2026
Disclosed
Mar 27, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 25 executedMar 27, 2026 disclosed

ACET · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ACET

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    AB
    Aftab BlakeChief Scientific Officer
    ACETAdicet Bio, Inc.
    Grant or award
    		A—
    55.0K sh
    		Jun 19, 2026Jun 23, 2026
    traded Jun 19, 2026
    		+4dSEC FORM 4

    Evidence

    9
    PK
    Peng KatieDirector
    ACETAdicet Bio, Inc.
    Grant or award
    		A—
    4,200 sh
    		Jun 21, 2026Jun 23, 2026
    traded Jun 21, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AB
    Aftab BlakeChief Scientific Officer
    ACETAdicet Bio, Inc.
    Grant or award
    		A—
    72.6K sh
    		Mar 25, 2026Mar 27, 2026
    traded Mar 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HD
    Healey DonChief Technology Officer
    ACETAdicet Bio, Inc.
    Grant or award
    		A—
    43.4K sh
    		Mar 25, 2026Mar 27, 2026
    traded Mar 25, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002052749-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 25, 2026
    Published
    Mar 27, 2026
    Ingested by INSIDER
    Nov 5, 04:09 UTC
    Last re-read
    Nov 5, 04:09 UTC

    Extracted facts

    Filer
    Maltzman Julia D.
    Role
    Chief Medical Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Adicet Bio, Inc. — Stock Option (Right to Buy)
    Ticker
    ACET
    Shares
    72.6K
    Price per share
    $0
    Execution date (reported)
    Mar 25, 2026
    Owned after transaction
    72.6K shares
    Days from execution to publication
    2

    What this establishes

    Maltzman Julia D. filed this Form 4 reporting a grant or award of ACET on Mar 25, 2026. It became public on Mar 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Medical Officer
    Maltzman Julia D.cik:0002052749
    Issuer
    Adicet Bio, Inc.cik:0001720580

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.